DR. LEFEBURE ANNEKE
ActiveSummary
DR. LEFEBURE ANNEKE has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €335,060 and a net result of €100,523. Equity has been shrinking by about 7.7% per year since 2018. Its solvency ranks better than 93% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 22-08-2006 Normal situation
- Activity
- Specialist medical practice NACE 86220and 3 others
- Establishment units
- 2.202.703.516 2600 Antwerpen, since 10-08-2006
- 2.202.703.714 2060 Antwerpen, since 10-08-2006and 1 other
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €123,934
- ▲ 22.5%
- Turnover
- ≈ €230,000
- estimated
- Profit
- €100,523
- ▲ 75.1%
- Equity
- €335,060
- ▲ 42.9%
- Total assets
- €350,395
- ▲ 15.3%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 22.60, cash €82,311Equity €335,060 (95.6% of total assets)Figures for financial year 2025 (filed on 27-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 61% on liquidity, 80% on profitability and 78% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Higher solvency than 92% of companies in human healthsector median 63.0% · 20,706 companies 95.6% View
- Positive: 8 profitable years in a rowprofit 2025: €100,523 8 years View
- Positive: Equity rose in 2025from €234,537 to €335,060 ▲ 42.9% View
- Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
Recent changes
- · Gazette deed Resignation: LEFEBURE Anneke (manager)Reappointment: LEFEBURE Anneke (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as DR. LEFEBURE ANNEKE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €321,000 and €362,000, founded between 2004 and 2009.
| Company | Total assets | Gross margin |
|---|---|---|
| DR. LEFEBURE ANNEKE Antwerpen | €350,395 | €123,934 |
| DR. CASAER ELKE Boechout | €362,108 | €116,464 |
| DR. LUC OEYEN Antwerpen | €320,777 | €123,160 |
| DR. MICHEL VANDEN BOGAERDE Sint-Katelijne-Waver | €335,850 | €121,244 |
| DR ANDRIANTAFIKA MAMISOA Ittre | €342,532 | €126,945 |
| Société médicale du docteur Hausman Thuin | €352,055 | €134,370 |
| DR. MC. DE JAEGER Wingene | €330,845 | €125,602 |
Key facts about DR. LEFEBURE ANNEKE
- What is the company number of DR. LEFEBURE ANNEKE?
- The company number of DR. LEFEBURE ANNEKE is 0883.086.317. The VAT number is the same number with BE in front: BE 0883.086.317.
- Where is DR. LEFEBURE ANNEKE based?
- The registered office is at Koninklijkelaan 70, 2600 Antwerpen.Company details
- What does DR. LEFEBURE ANNEKE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. LEFEBURE ANNEKE?
- The legal form of DR. LEFEBURE ANNEKE is Private limited company (BV).
- When was DR. LEFEBURE ANNEKE founded?
- DR. LEFEBURE ANNEKE was founded on 22-08-2006.
- Is DR. LEFEBURE ANNEKE still active?
- Yes, DR. LEFEBURE ANNEKE is an active enterprise in the KBO register.
- What is the turnover of DR. LEFEBURE ANNEKE?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €123,934 and 42 comparable companies (NACE 86220). It probably lies between €200,000 and €300,000.Financials
- Is DR. LEFEBURE ANNEKE profitable?
- In financial year 2025, DR. LEFEBURE ANNEKE made a profit of €100,523.
- Where can I find the annual accounts of DR. LEFEBURE ANNEKE?
- DR. LEFEBURE ANNEKE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. LEFEBURE ANNEKE due?
- DR. LEFEBURE ANNEKE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.